- Agilent Technologies, headquartered in Santa Clara, California, specializes in scientific and photographic control equipment, focusing on advanced solutions in life sciences, diagnostics, and applied chemical markets.
- In March 2026, Agilent announced the acquisition of Biocare Medical for $950 million, enhancing its pathology portfolio with complementary antibody and reagent offerings that have shown double-digit revenue growth since 2021.
- Agilent serves a diverse customer base, including healthcare and research institutions, and has recently showcased innovations in precision oncology and digital pathology at major industry events.
- Ideal buyers for Agilent include clinical laboratories and research organizations seeking cutting-edge diagnostic tools and solutions to improve patient outcomes, making them a key player in the rapidly evolving healthcare landscape.
Agilent Technologies operates with a diverse departmental structure, comprising 19 distinct areas. The largest department is Operations, with a headcount of 2,070 employees, followed by Information Technology, which employs 1,220. Sales, Engineering, and Community and Social Services also contribute significantly to the workforce, reflecting a balanced functional mix that supports both operational and technological needs.
The company maintains a broad geographic footprint with 484 locations, predominantly concentrated in California. The largest site is in Santa Clara, CA, housing 1,132 employees, followed by Wilmington, DE, with 278 employees. The substantial headcount categorized as 'Other' indicates a distributed workforce across various regions, highlighting Agilent's extensive operational reach.
